Literature DB >> 16365806

Herpes zoster panuveitis progression despite acyclovir treatment in a patient following bone marrow transplantation.

Osamutaro Fujiwara1, Yoshinori Mitamura2, Kenji Ohtsuka2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365806     DOI: 10.1007/s10384-005-0247-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

Review 1.  Varicella-zoster virus eye disease.

Authors:  T J Liesegang
Journal:  Cornea       Date:  1999-09       Impact factor: 2.651

Review 2.  Diagnosis and therapy of herpes zoster ophthalmicus.

Authors:  T J Liesegang
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

Review 3.  The potential impact of the varicella vaccine and new antivirals on ocular disease related to varicella-zoster virus.

Authors:  J S Pepose
Journal:  Am J Ophthalmol       Date:  1997-02       Impact factor: 5.258

4.  Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  M A Jacobson; T G Berger; S Fikrig; P Becherer; J W Moohr; S C Stanat; K K Biron
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

5.  Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison.

Authors:  Elisabetta Miserocchi; Nadia K Waheed; Enrique Dios; William Christen; Jesus Merayo; Manolette Roque; C Stephen Foster
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

  5 in total
  1 in total

Review 1.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.